Navigation Links
Depomed Reports Third Quarter 2013 Financial Results
Date:11/5/2013

ssociated with our Phase 2 clinical trial of DM-1992 in third quarter 2012.

Net income for the third quarter of 2013 was $6.5 million or $0.11 per share, compared to a net loss of ($1.5) million or ($0.03) per share for the third quarter of 2012.

Cash and marketable securities were $85.4 million as of September 30, 2013 as compared to $74.2 million as of June 30, 2013. This does not include proceeds from the sale of type 2 diabetes milestones and royalties to PDL BioPharma, announced in October 2013.

Revised 2013 Guidance in Light of PDL Transaction Depomed is revising the financial outlook previously given for the full year of 2013 resulting from the sale of milestone and royalty interests in Depomed's type 2 diabetes portfolio to PDL Biopharma in October 2013.

  • Operating expenses of approximately $116 to $118 million, which includes intangible amortization related to the acquisitions of Zipsor and Lazanda.
  • Depomed is revising its revenue guidance for 2013 to a range of approximately $113 to $116 million. This guidance removes revenues related to the type 2 diabetes interests sold to PDL for the fourth quarter of 2013 and does not include a potential $10 million approval milestone from Mallinckrodt.  Depomed is still reviewing the accounting for the PDL transaction, which could have an effect on reported revenues under US GAAP.
  • Year-end 2013 cash and marketable securities of $318 to $322 million prior to consideration of taxes that may result from the PDL transaction and does not include receipt of a potential $10 million approval milestone from Mallinckrodt before year end.
  • Conference CallDepomed will host a conference call today, Tuesday, November 5 beginning at 5:00 p.m. EST (2:00 p.m. PST) to discuss its results.  Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on the investor
    '/>"/>

    SOURCE Depomed, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
    2. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
    3. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
    4. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
    5. Depomed Reports Second Quarter 2013 Financial Results
    6. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
    7. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
    8. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
    9. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
    10. Depomed To Present At Jefferies 2013 Global Healthcare Conference
    11. Depomed Reports First Quarter 2013 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... Aug. 21, 2014   Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced positive results from a ... histolyticum (or CCH) for the treatment of edematous ... the Phase 2a trial, all three doses of ... showed an improvement in the appearance of cellulite ...
    (Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
    (Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
    Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
    (Date:8/22/2014)... 2014 The first ORTC Public ... Microsoft, and Google. ( http://ortc.org/wp-content/uploads/2014/08/ortc.html ) , ... to create a WebRTC 1.1 API with exceptional ... WebRTC, ORTC (Object Real-time Communication) enables plugin-free real-time ... specifically tailored to provide the direct control needed ...
    (Date:8/22/2014)... California (PRWEB) August 22, 2014 The ... , BillionaireFish.com, recently registered its two millionth member, and ... threshold. , Billionairefish.com is a dating website for ... women to date. The dating website caters like-minded people ... dating site for the rich , this is ...
    (Date:8/22/2014)... New York, NY (PRWEB) August 22, 2014 ... at NY Heart Health Clinics are promoting non-invasive ... four most preventable risks of cardiovascular morbidity and ... heart disease, stroke, Deep Vein Thrombosis and Pulmonary ... Health Clinics are promoting painless, noninvasive screening at ...
    (Date:8/22/2014)... CA (PRWEB) August 22, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... , The US FDA announced on August 19, that ... Systems, model number DPB-125MICRO145 (Part number 7-10003), by Cardiovascular ... defective saline sheaths that could fracture during use and ...
    (Date:8/22/2014)... (PRWEB) August 22, 2014 The Berkowitz ... behalf of a client who suffered severe, permanent injuries ... old drunk driver (docket number FST-CV13-6018309-S). The case was ... mediation. , According to Jennifer Amdur of The Berkowitz ... the case, all of whom were allegedly ...
    Breaking Medicine News(10 mins):Health News:Hookflash, Google and Microsoft lead on ORTC / WebRTC 1.1 Public Draft 2Health News:Hookflash, Google and Microsoft lead on ORTC / WebRTC 1.1 Public Draft 3Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 2Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 3Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:The Berkowitz Law Firm LLC Reaches a $2 Million Settlement for a Client Allegedly Injured in Drunk Driving Accident 2
    ... Calif., June 5 The Service Employees,International Union ... attack on Sen. Barack Obama,s healthcare plan as ... registered nurses, the,California Nurses Association/National Nurses Organizing Committee ... this week, SEIU blasts CNA/NNOC for,supporting a "government-run ...
    ... Officials at,Southern Research Institute, a not-for-profit ... the areas of preclinical drug discovery, drug,and ... today announced that Charles D. McCrary, President ... has joined the company,s Board,of Directors., ...
    ... these foods may also counteract damage tobacco does to ... -- Eating fruits and vegetables rich in flavonoids and ... say researchers from the University of California, Los Angeles ... antioxidant and anti-inflammatory properties that can counteract damage to ...
    ... retail drug,store sales for the four-week and seventeen-week periods ended May 29,2008., ... Periods ended May 29, 2008 ... Month Year to Date (Dollars in millions) ... (17 weeks), Total retail drug store sales ...
    ... June 5 Universal Health,Realty Income Trust (NYSE: ... to increase the quarterly dividend by $.005 and pay ... to shareholders of record as of June 16,2008., ... trust,invests in healthcare and human service related facilities including ...
    ... fat metabolism , , THURSDAY, June 5 (HealthDay News) -- ... familiar to the diet-conscious choosing between carrots and carrot ... just a matter of what you put in your ... predisposed to process fat. , The theory is based ...
    Cached Medicine News:Health News:Service Employee Union's Latest Attack on RNs Parrots McCain's Attack on Obama's Health Plan 2Health News:Service Employee Union's Latest Attack on RNs Parrots McCain's Attack on Obama's Health Plan 3Health News:Charles D. McCrary Joins Southern Research Institute Board of Directors 2Health News:Fruits, Vegetables, Teas May Cut Smokers' Cancer Risk 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:Weight Gain May Not Be Based Just on What You Eat 2Health News:Weight Gain May Not Be Based Just on What You Eat 3
    ... all silicone cuff is totally ... dimension to the outer diameter ... it can be partially or ... management needs. TTS™ is the ...
    ... The forgiving nature of the silicone ... range of mobility and more comfort than ... ,The soft, comfortable and compliant neck ... with minimal stoma irritation. A comprehensive range ...
    ... (TTS™) cuff facilitates stomal insertion., ,Adult ... include a trach tie, disconnect wedge, and ... tracheostomy tubes are intended for temporary use ... tube can be obtained. Not for home ...
    ... termination for easy ventilator circuit attachment with ... ,Clearly the softer choice in a ... ,The Portex® flexible disposable inner cannula tracheostomy ... providing a softer and more pliable tube ...
    Medicine Products: